Table 1.
The association of IGFBPL1 methylation and clinical factors in human ESCC
| Clinical factor | Number | IGFBPL1 methylation status | P value | |
|---|---|---|---|---|
| Unmethylated n = 255 50.28% | Methylated n = 246 49.10% | |||
| Age (years) | 0.167 | |||
| < 63 | 252 | 136 | 116 | |
| ≥ 63 | 249 | 119 | 130 | |
| Gender | 0.102 | |||
| Male | 316 | 152 | 164 | |
| Female | 185 | 103 | 82 | |
| Tumor size (cm) | 0.009** | |||
| < 4 | 254 | 144 | 110 | |
| ≥ 4 | 247 | 111 | 136 | |
| Differentiation | 0.518 | |||
| Well or moderate | 390 | 200 | 190 | |
| Poor | 111 | 55 | 56 | |
| Lymph node metastasis | 0.131 | |||
| Negative | 310 | 166 | 144 | |
| Positive | 191 | 89 | 102 | |
| TNM stage | 0.012* | |||
| Stage I-II | 295 | 164 | 131 | |
| Stage III-VI | 206 | 91 | 115 | |
| Distal metastasis | 0.070 | |||
| Yes | 58 | 36 | 22 | |
| No | 443 | 219 | 224 | |
| Cancer embolus | 0.848 | |||
| Yes | 15 | 8 | 7 | |
| No | 486 | 247 | 239 | |
| Smoking | 0.277 | |||
| Yes | 271 | 144 | 127 | |
| No | 230 | 111 | 119 | |
| Drinking | 0.136 | |||
| Yes | 116 | 52 | 64 | |
| No | 385 | 203 | 182 | |
| Inherited | 0.806 | |||
| Yes | 136 | 68 | 68 | |
| No | 365 | 187 | 178 | |
P values are obtained from chi-square test, significant difference
*p < 0.05
**p < 0.01